<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pmed.1002678.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pmed.1002678.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Key characteristics of proposed HIV epidemic transition metrics and their benchmark values.</title>
 </caption>
 <alternatives>
  <graphic id="pmed.1002678.t001g" xlink:href="pmed.1002678.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1"/>
     <th align="left" rowspan="1" colspan="1">HIV incidence rate</th>
     <th align="left" rowspan="1" colspan="1">AIDS-related mortality rate</th>
     <th align="left" rowspan="1" colspan="1">HIV incidence reduction compared to 2010: 75% by 2020 and 90% by 2030</th>
     <th align="left" rowspan="1" colspan="1">AIDS-related mortality reduction compared to 2010: 75% by 2020 and 90% by 2030</th>
     <th align="left" rowspan="1" colspan="1">Ratio of new HIV infections over PLHIV (IPR)</th>
     <th align="left" rowspan="1" colspan="1">Ratio of new HIV infections over all-cause mortality among PLHIV (IMR)</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Benchmark value</td>
     <td align="left" rowspan="1" colspan="1">To be set locally</td>
     <td align="left" rowspan="1" colspan="1">To be set locally</td>
     <td align="left" rowspan="1" colspan="1">75% by 2020
      <break/>90% by 2030
     </td>
     <td align="left" rowspan="1" colspan="1">75% by 2020
      <break/>90% by 2030
     </td>
     <td align="left" rowspan="1" colspan="1">0.03</td>
     <td align="left" rowspan="1" colspan="1">1</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Complexity</td>
     <td align="left" rowspan="1" colspan="1">Simple: a single rate in a given year, although the target will need to be setting specific.</td>
     <td align="left" rowspan="1" colspan="1">Simple: a single rate in a given year, although the target will need to be setting specific.</td>
     <td align="left" rowspan="1" colspan="1">Intermediate: comparison of two numbers</td>
     <td align="left" rowspan="1" colspan="1">Intermediate: comparison of two numbers</td>
     <td align="left" rowspan="1" colspan="1">Complex: ratio between two quantities</td>
     <td align="left" rowspan="1" colspan="1">Complex: ratio between two quantities (and requires an ancillary condition regarding low mortality)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Use</td>
     <td align="left" rowspan="1" colspan="1">Adopted as main indicator for monitoring SDG 3.3.1.
      <break/>Regularly used by countries and organisations.
     </td>
     <td align="left" rowspan="1" colspan="1">Regularly used by countries and organisations.</td>
     <td align="left" rowspan="1" colspan="1">Many countries have adopted national targets for 2020.</td>
     <td align="left" rowspan="1" colspan="1">Few countries have adopted national targets.</td>
     <td align="left" rowspan="1" colspan="1">Few countries have used [
      <xref rid="pmed.1002678.ref004" ref-type="bibr">4</xref>–
      <xref rid="pmed.1002678.ref009" ref-type="bibr">9</xref>].
     </td>
     <td align="left" rowspan="1" colspan="1">PEPFAR has proposed in its strategies [
      <xref rid="pmed.1002678.ref022" ref-type="bibr">22</xref>,
      <xref rid="pmed.1002678.ref023" ref-type="bibr">23</xref>].
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Relevance for countries</td>
     <td align="left" rowspan="1" colspan="1">Metric applies to all countries, but benchmark value changes relative to the level of countries’ incidence rate.</td>
     <td align="left" rowspan="1" colspan="1">Metric applies to all countries, but benchmark value changes relative to the level of countries’ AIDS-related mortality rate.</td>
     <td align="left" rowspan="1" colspan="1">Applies to all countries, regardless of number of new infections in 2010.</td>
     <td align="left" rowspan="1" colspan="1">Applies to all countries, regardless of number of AIDS-related deaths in 2010.</td>
     <td align="left" rowspan="1" colspan="1">Applies to epidemics of all sizes, regardless of the level of incidence or prevalence.</td>
     <td align="left" rowspan="1" colspan="1">Applies to epidemics of all sizes, regardless of the level of incidence or mortality.</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Rooted in epidemiological theory about the sustainability of transmission?</td>
     <td align="left" rowspan="1" colspan="1">No—but the threshold can be setting specific and chosen according to empirical evidence on HIV incidence rates.</td>
     <td align="left" rowspan="1" colspan="1">No—but the threshold can be setting specific and chosen according to empirical evidence on AIDS death rates.</td>
     <td align="left" rowspan="1" colspan="1">Partially.
      <break/>The targets are derived using a model that represents the potential impact on the epidemic of a suite of interventions.
     </td>
     <td align="left" rowspan="1" colspan="1">Partially.
      <break/>The targets are derived using a model that represents the potential impact on the epidemic of a suite of interventions.
     </td>
     <td align="left" rowspan="1" colspan="1">Yes</td>
     <td align="left" rowspan="1" colspan="1">Yes
      <break/>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Impact of target achievement on burdens:
      <break/>a. Sickness, death
      <break/>b. Fiscal burden
     </td>
     <td align="left" rowspan="1" colspan="1">a. Eventually reduces
      <break/>b. Eventually reduces
     </td>
     <td align="left" rowspan="1" colspan="1">a. Immediately reduces
      <break/>b. Eventually reduces
     </td>
     <td align="left" rowspan="1" colspan="1">a. Eventually reduces
      <break/>b. Eventually reduces
     </td>
     <td align="left" rowspan="1" colspan="1">a. Immediately reduces
      <break/>b. Eventually reduces
     </td>
     <td align="left" rowspan="1" colspan="1">a. Eventually reduces
      <break/>b. Reduces when incidence is lower than all-cause mortality among HIV+ people
     </td>
     <td align="left" rowspan="1" colspan="1">a. Immediately reduces*
      <break/>b. Immediately reduces*
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Other</td>
     <td align="left" rowspan="1" colspan="1">No universal benchmark values exist, as they will change from country to country and by population subgroups.</td>
     <td align="left" rowspan="1" colspan="1">No universal benchmark values exist, as they will change from country to country and by population subgroups.</td>
     <td align="left" rowspan="1" colspan="1">A 90% reduction in incidence in one place by 2030 could leave incidence at a higher incidence than somewhere else in 2010—i.e., the metric is permissive to global heterogeneity in epidemic levels.</td>
     <td align="left" rowspan="1" colspan="1">A 90% reduction in AIDS-related mortality in one place by 2030 could leave AIDS-related mortality at a higher level than somewhere else in 2010—i.e., the metric is permissive to global heterogeneity in epidemic levels.</td>
     <td align="left" rowspan="1" colspan="1">Applies to national or regional populations, not to subgroups of the population for which HIV transmission occurs between the groups, notably sex- and age-defined groups, and to varying degrees key population groups, including sex workers, transgender people, men who have sex with men, and people who inject drugs.</td>
     <td align="left" rowspan="1" colspan="1">Applies to national or regional populations, not to subgroups of the population for which HIV transmission occurs between the groups, notably sex- and age-defined groups, and to varying degrees key population groups, including sex workers, transgender people, men who have sex with men, and people who inject drugs.</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>* When associated with an important reduction in mortality as discussed in the text.</p>
  </fn>
  <fn id="t001fn002">
   <p>Abbreviations: IMR, incidence:mortality ratio; IPR, incidence:prevalence ratio; PEPFAR, President’s Emergency Plan for AIDS Relief; PLHIV, people living with HIV; SDG, Sustainable Development Goal.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
